Cargando…
Interaction of tamoxifen with the multidrug resistance P-glycoprotein.
Tamoxifen is an anti-oestrogen which is currently being assessed as a prophylactic for women at high risk of breast cancer. Taxoxifen has also been shown to reverse multidrug resistance in P-glycoprotein (P-gp)-expressing cells, although the mechanism of action is unknown. In this study we demonstra...
Autores principales: | Callaghan, R., Higgins, C. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033580/ https://www.ncbi.nlm.nih.gov/pubmed/7841043 |
Ejemplares similares
-
The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells
por: Bakadlag, Rowa, et al.
Publicado: (2023) -
Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
por: Dale, I. L., et al.
Publicado: (1998) -
Cortisol is transported by the multidrug resistance gene product P-glycoprotein.
por: van Kalken, C. K., et al.
Publicado: (1993) -
Reversal of acquired resistance to adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: role of drug interaction with alpha 1 acid glycoprotein.
por: Chatterjee, M., et al.
Publicado: (1990) -
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers
por: Frye, William J. E., et al.
Publicado: (2023)